SLS
SELLAS Life Sciences Group, Inc. · Healthcare · Market cap $2.7B
Insider Buying
$101K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Latest filing
Jun 18, 2026
Kalin Katherine Bach
SELLAS Life Sciences Group, Inc. (SLS) has 12 SEC Form 4 filings (12 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jun 18, 2026.
Inside the rolling window, 1 insider at SELLAS Life Sciences Group, Inc. reported 1 open-market purchase totaling $101K and no open-market sales. The most recent open-market filing is a purchase of 63,400 shares by Director Kalin Katherine Bach, dated Nov 19, 2025, worth $101K.
- Industry:Biotechnology
- CEO:Angelos Stergiou
- Employees:13
- HQ:New York, NY, US
- IPO:2008-03-12
| Source | |||||||
|---|---|---|---|---|---|---|---|
Kalin Katherine BachFirst filing | Director | Purchase | 63,400 | $101K | Nov 21 | +781.7% | SEC ↗ |
Reddit mentions
See all →SLS is the #14 most-discussed ticker across finance subreddits, with 8 mentions in the last 24 hours, -20 vs the day before, hottest in r/WallStreetBets.
Mention counts are conversation volume, not a quality signal. Not investment advice.
Frequently asked questions
How many SEC Form 4 insider filings does SLS have?
SELLAS Life Sciences Group, Inc. (SLS) has 12 SEC Form 4 filings (12 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Jun 18, 2026.
When was the most recent SEC Form 4 filing for SLS?
The most recent Form 4 filing for SLS on Tracefour is dated Jun 18, 2026.
What is the total insider buy and sell value at SLS in the current window?
Inside the rolling window, insiders at SLS bought $101K and sold $0 based on SEC Form 4 filings.
Can I get alerts for SLS insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at SELLAS Life Sciences Group, Inc. (SLS). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
SELLAS Life Sciences Group, Inc. is in the Healthcare sector.